KEGG pathway . | P-value . | FDR . | NES . | Top genes . |
---|---|---|---|---|
Upregulated | ||||
Extracellular matrix receptor interaction | 0.0001 | 0.107 | 1.82 | ITGA5, LAMA3, COL6A6 |
Adherens junction | 0.0001 | 0.072 | 1.79 | IGF1R, LMO7, FER |
Neuroactive ligand receptor interaction | 0.0001 | 0.083 | 1.72 | CHRNG, CYSLTR1, P2RX7, CHRND |
P53 signalling pathway | 0.0001 | 0.094 | 1.67 | SESN3, MDM4, CCNE2 |
Viral myocarditis | 0.016 | 0.208 | 1.54 | HLA-DMB, ICAM1, HLA-DMA |
Cell adhesion molecules | 0.023 | 0.463 | 1.39 | SIGLEC1, HLA-DMB, ICAM1 |
Nod-like receptor signalling pathway | 0.030 | 0.476 | 1.36 | NOD1, CARD8, NAIP |
Axon guidance | 0.049 | 0.462 | 1.31 | NFATC4, SEMA6A, SEMA3G |
Focal adhesion | 0.0001 | 0.531 | 1.23 | IGF1R, HGF, MYLK |
Downregulated | ||||
Ribosome | 0.0001 | 0.0001 | −3.11 | RPS15A, RPS26, FAU |
Oxidative phosphorylation | 0.0001 | 0.0001 | −2.87 | NDUFB3, COX7B, ATP5MC1 |
Proteasome | 0.0001 | 0.0001 | −2.13 | POMP, PSMF1, PSMB6 |
Citric acid cycle | 0.0001 | 0.0001 | −2.01 | SDHB, SDHD, SUCLG1 |
RNA polymerase | 0.0001 | 0.0001 | −2.00 | POLR3K, POLR2K, POL2RL |
Glycine, serine and threonine metabolism | 0.0001 | 0.001 | −1.91 | PHGDH, SHMT1, CTH |
Gluthatione metabolism | 0.0001 | 0.001 | −1.90 | GSTM5, GPX4, IDH2 |
Glycolysis–gluconeogenesis | 0.0001 | 0.002 | −1.89 | ENO3, BPGM, ALDOA |
Drug metabolism cytochrome P450 | 0.001 | 0.003 | −1.85 | GSTM5, GSTO1, GSTM4 |
Pyruvate metabolism | 0.001 | 0.003 | −1.84 | LDHD, PC, MDH2 |
Lysosome | 0.0001 | 0.003 | −1.83 | ATP6V0B, LAPTM4A, DNASE2 |
Valine, leucine and isoleucine degradation | 0.001 | 0.004 | −1.80 | ECHS1, HSD17B10, BCKDHA |
Glycosilphosphatidylinositol biosynthesis | 0.01 | 0.016 | −1.68 | PIGP, DPM2, PIGZ |
Protein export | 0.004 | 0.022 | −1.64 | SPCS1, SRP14, SRP9 |
Cysteine metabolism | 0.04 | 0.086 | −1.49 | GOT2, ADI1, CTH |
KEGG pathway . | P-value . | FDR . | NES . | Top genes . |
---|---|---|---|---|
Upregulated | ||||
Extracellular matrix receptor interaction | 0.0001 | 0.107 | 1.82 | ITGA5, LAMA3, COL6A6 |
Adherens junction | 0.0001 | 0.072 | 1.79 | IGF1R, LMO7, FER |
Neuroactive ligand receptor interaction | 0.0001 | 0.083 | 1.72 | CHRNG, CYSLTR1, P2RX7, CHRND |
P53 signalling pathway | 0.0001 | 0.094 | 1.67 | SESN3, MDM4, CCNE2 |
Viral myocarditis | 0.016 | 0.208 | 1.54 | HLA-DMB, ICAM1, HLA-DMA |
Cell adhesion molecules | 0.023 | 0.463 | 1.39 | SIGLEC1, HLA-DMB, ICAM1 |
Nod-like receptor signalling pathway | 0.030 | 0.476 | 1.36 | NOD1, CARD8, NAIP |
Axon guidance | 0.049 | 0.462 | 1.31 | NFATC4, SEMA6A, SEMA3G |
Focal adhesion | 0.0001 | 0.531 | 1.23 | IGF1R, HGF, MYLK |
Downregulated | ||||
Ribosome | 0.0001 | 0.0001 | −3.11 | RPS15A, RPS26, FAU |
Oxidative phosphorylation | 0.0001 | 0.0001 | −2.87 | NDUFB3, COX7B, ATP5MC1 |
Proteasome | 0.0001 | 0.0001 | −2.13 | POMP, PSMF1, PSMB6 |
Citric acid cycle | 0.0001 | 0.0001 | −2.01 | SDHB, SDHD, SUCLG1 |
RNA polymerase | 0.0001 | 0.0001 | −2.00 | POLR3K, POLR2K, POL2RL |
Glycine, serine and threonine metabolism | 0.0001 | 0.001 | −1.91 | PHGDH, SHMT1, CTH |
Gluthatione metabolism | 0.0001 | 0.001 | −1.90 | GSTM5, GPX4, IDH2 |
Glycolysis–gluconeogenesis | 0.0001 | 0.002 | −1.89 | ENO3, BPGM, ALDOA |
Drug metabolism cytochrome P450 | 0.001 | 0.003 | −1.85 | GSTM5, GSTO1, GSTM4 |
Pyruvate metabolism | 0.001 | 0.003 | −1.84 | LDHD, PC, MDH2 |
Lysosome | 0.0001 | 0.003 | −1.83 | ATP6V0B, LAPTM4A, DNASE2 |
Valine, leucine and isoleucine degradation | 0.001 | 0.004 | −1.80 | ECHS1, HSD17B10, BCKDHA |
Glycosilphosphatidylinositol biosynthesis | 0.01 | 0.016 | −1.68 | PIGP, DPM2, PIGZ |
Protein export | 0.004 | 0.022 | −1.64 | SPCS1, SRP14, SRP9 |
Cysteine metabolism | 0.04 | 0.086 | −1.49 | GOT2, ADI1, CTH |
FDR = false discovery rate; GSEA = gene set enrichment analysis; NES = normalized enrichment score.
KEGG pathway . | P-value . | FDR . | NES . | Top genes . |
---|---|---|---|---|
Upregulated | ||||
Extracellular matrix receptor interaction | 0.0001 | 0.107 | 1.82 | ITGA5, LAMA3, COL6A6 |
Adherens junction | 0.0001 | 0.072 | 1.79 | IGF1R, LMO7, FER |
Neuroactive ligand receptor interaction | 0.0001 | 0.083 | 1.72 | CHRNG, CYSLTR1, P2RX7, CHRND |
P53 signalling pathway | 0.0001 | 0.094 | 1.67 | SESN3, MDM4, CCNE2 |
Viral myocarditis | 0.016 | 0.208 | 1.54 | HLA-DMB, ICAM1, HLA-DMA |
Cell adhesion molecules | 0.023 | 0.463 | 1.39 | SIGLEC1, HLA-DMB, ICAM1 |
Nod-like receptor signalling pathway | 0.030 | 0.476 | 1.36 | NOD1, CARD8, NAIP |
Axon guidance | 0.049 | 0.462 | 1.31 | NFATC4, SEMA6A, SEMA3G |
Focal adhesion | 0.0001 | 0.531 | 1.23 | IGF1R, HGF, MYLK |
Downregulated | ||||
Ribosome | 0.0001 | 0.0001 | −3.11 | RPS15A, RPS26, FAU |
Oxidative phosphorylation | 0.0001 | 0.0001 | −2.87 | NDUFB3, COX7B, ATP5MC1 |
Proteasome | 0.0001 | 0.0001 | −2.13 | POMP, PSMF1, PSMB6 |
Citric acid cycle | 0.0001 | 0.0001 | −2.01 | SDHB, SDHD, SUCLG1 |
RNA polymerase | 0.0001 | 0.0001 | −2.00 | POLR3K, POLR2K, POL2RL |
Glycine, serine and threonine metabolism | 0.0001 | 0.001 | −1.91 | PHGDH, SHMT1, CTH |
Gluthatione metabolism | 0.0001 | 0.001 | −1.90 | GSTM5, GPX4, IDH2 |
Glycolysis–gluconeogenesis | 0.0001 | 0.002 | −1.89 | ENO3, BPGM, ALDOA |
Drug metabolism cytochrome P450 | 0.001 | 0.003 | −1.85 | GSTM5, GSTO1, GSTM4 |
Pyruvate metabolism | 0.001 | 0.003 | −1.84 | LDHD, PC, MDH2 |
Lysosome | 0.0001 | 0.003 | −1.83 | ATP6V0B, LAPTM4A, DNASE2 |
Valine, leucine and isoleucine degradation | 0.001 | 0.004 | −1.80 | ECHS1, HSD17B10, BCKDHA |
Glycosilphosphatidylinositol biosynthesis | 0.01 | 0.016 | −1.68 | PIGP, DPM2, PIGZ |
Protein export | 0.004 | 0.022 | −1.64 | SPCS1, SRP14, SRP9 |
Cysteine metabolism | 0.04 | 0.086 | −1.49 | GOT2, ADI1, CTH |
KEGG pathway . | P-value . | FDR . | NES . | Top genes . |
---|---|---|---|---|
Upregulated | ||||
Extracellular matrix receptor interaction | 0.0001 | 0.107 | 1.82 | ITGA5, LAMA3, COL6A6 |
Adherens junction | 0.0001 | 0.072 | 1.79 | IGF1R, LMO7, FER |
Neuroactive ligand receptor interaction | 0.0001 | 0.083 | 1.72 | CHRNG, CYSLTR1, P2RX7, CHRND |
P53 signalling pathway | 0.0001 | 0.094 | 1.67 | SESN3, MDM4, CCNE2 |
Viral myocarditis | 0.016 | 0.208 | 1.54 | HLA-DMB, ICAM1, HLA-DMA |
Cell adhesion molecules | 0.023 | 0.463 | 1.39 | SIGLEC1, HLA-DMB, ICAM1 |
Nod-like receptor signalling pathway | 0.030 | 0.476 | 1.36 | NOD1, CARD8, NAIP |
Axon guidance | 0.049 | 0.462 | 1.31 | NFATC4, SEMA6A, SEMA3G |
Focal adhesion | 0.0001 | 0.531 | 1.23 | IGF1R, HGF, MYLK |
Downregulated | ||||
Ribosome | 0.0001 | 0.0001 | −3.11 | RPS15A, RPS26, FAU |
Oxidative phosphorylation | 0.0001 | 0.0001 | −2.87 | NDUFB3, COX7B, ATP5MC1 |
Proteasome | 0.0001 | 0.0001 | −2.13 | POMP, PSMF1, PSMB6 |
Citric acid cycle | 0.0001 | 0.0001 | −2.01 | SDHB, SDHD, SUCLG1 |
RNA polymerase | 0.0001 | 0.0001 | −2.00 | POLR3K, POLR2K, POL2RL |
Glycine, serine and threonine metabolism | 0.0001 | 0.001 | −1.91 | PHGDH, SHMT1, CTH |
Gluthatione metabolism | 0.0001 | 0.001 | −1.90 | GSTM5, GPX4, IDH2 |
Glycolysis–gluconeogenesis | 0.0001 | 0.002 | −1.89 | ENO3, BPGM, ALDOA |
Drug metabolism cytochrome P450 | 0.001 | 0.003 | −1.85 | GSTM5, GSTO1, GSTM4 |
Pyruvate metabolism | 0.001 | 0.003 | −1.84 | LDHD, PC, MDH2 |
Lysosome | 0.0001 | 0.003 | −1.83 | ATP6V0B, LAPTM4A, DNASE2 |
Valine, leucine and isoleucine degradation | 0.001 | 0.004 | −1.80 | ECHS1, HSD17B10, BCKDHA |
Glycosilphosphatidylinositol biosynthesis | 0.01 | 0.016 | −1.68 | PIGP, DPM2, PIGZ |
Protein export | 0.004 | 0.022 | −1.64 | SPCS1, SRP14, SRP9 |
Cysteine metabolism | 0.04 | 0.086 | −1.49 | GOT2, ADI1, CTH |
FDR = false discovery rate; GSEA = gene set enrichment analysis; NES = normalized enrichment score.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.